Form 4: Apogee Therapeutics CFO Jane Henderson Sells 6,000 Shares
SEC Form 4
Jane Henderson, CFO of Apogee Therapeutics, sold 6,000 shares of common stock on August 23, 2024, at a price of $48.26 per share.
Summary
- On August 23, 2024, Jane Henderson, the Chief Financial Officer of Apogee Therapeutics, sold 6,000 shares of the company's common stock.
- The sale was executed at a price of $48.26 per share.
- Following the transaction, Henderson directly owns 200,871 shares of Apogee Therapeutics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This is a routine disclosure of an insider transaction. Monitoring insider transactions can provide insights into management's perspective on the company's valuation and future prospects, but one sale is not necessarily indicative of a trend.
Stakeholder Impact
- The sale of shares by a key executive could be perceived negatively by some shareholders, potentially leading to minor short-term price fluctuations.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date of stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.